Cart
sales@molnova.com
SFI003
CAS No. 2361332-90-1
SFI003( —— )
Catalog No. M36429 CAS No. 2361332-90-1
SFI003 is a novel SRSF3 inhibitor that exerts anticancer activity against colorectal cancer by modulating the SRSF3 / DHCR24 / ROS axis and driving apoptosis in CRC cells through the SRSF3 / DHCR24 / reactive oxygen species (ROS) axis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 128 | Get Quote |
|
| 5MG | 200 | Get Quote |
|
| 10MG | 304 | Get Quote |
|
| 25MG | 506 | Get Quote |
|
| 50MG | 729 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 500MG | 1971 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSFI003
-
NoteResearch use only, not for human use.
-
Brief DescriptionSFI003 is a novel SRSF3 inhibitor that exerts anticancer activity against colorectal cancer by modulating the SRSF3 / DHCR24 / ROS axis and driving apoptosis in CRC cells through the SRSF3 / DHCR24 / reactive oxygen species (ROS) axis.
-
DescriptionSFI003 is a novel SRSF3 inhibitor that exerts anticancer activity against colorectal cancer by modulating the SRSF3 / DHCR24 / ROS axis and driving apoptosis in CRC cells through the SRSF3 / DHCR24 / reactive oxygen species (ROS) axis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetROS
-
RecptorROS | Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2361332-90-1
-
Formula Weight363.44
-
Molecular FormulaC19H17N5OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=N\NC1=NC(=CS1)C2=CC=C(OC)C=C2)(\C)/C=3NC=4C(N3)=CC=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(E/Z)-GSK5182
(E/Z)-GSK5182 (GSK5182(Z/E)) is a racemic mixture comprising (E)-GSK5182 and (Z)-GSK5182 isomers.
-
Taletrectinib free b...
Taletrectinib free base (AB-106 free base) is a novel potent, selective and orally active ROS1/NTRK inhibitor.
-
MJ33 lithium salt
MJ33 lithium salt is an inhibitor of NADPH oxidase type 2-mediated ROS generation, a fluorinated phospholipid analog that inhibits the phospholipase A2 (PLA2) activity of peroxiredoxin 6 (Prdx6), and is used in the study of acute lung injury.
